All In Biotech

Free tool

FAERS Monitor: Femara

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020726 or its brand name (Femara, Letrozole). Reports on generic versions are filed under their own applications.

Reports

62,445

Serious

50,509

81% of reports

Hospitalization

15,972

Death reported

6,134

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue7,561
  • nausea5,594
  • neutropenia5,295
  • diarrhoea4,792
  • malignant neoplasm progression4,614
  • arthralgia4,046
  • white blood cell count decreased3,845
  • alopecia3,711
  • pain3,097
  • asthenia3,034
  • dyspnoea2,976
  • vomiting2,820
  • neoplasm progression2,791
  • death2,738
  • headache2,537

Reports by year received

View as table
YearReports
2004155
2005305
2006463
2007438
2008515
2009606
2010934
20111,099
20121,083
2013869
2014827
20151,937
20163,080
20173,344
20184,475
20195,738
20205,880
20216,044
20225,875
20235,949
20245,025
20254,538
20263,266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,714 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neoplasm progressionSignal2,79129.328.270,295
malignant neoplasm progressionSignal4,61415.815.461,562
neutropeniaSignal5,29513.613.359,819
white blood cell count decreasedSignal3,84512.312.038,875
alopeciaSignal3,7116.56.316,984
arthralgiaSignal4,0463.33.26,550
fatigueSignal7,5613.33.212,415
astheniaSignal3,0342.72.63,362
diarrhoeaSignal4,7922.52.44,463
nauseaSignal5,5942.42.34,667
vomitingSignal2,8202.02.01,489
dyspnoea2,9761.81.71,028
pain3,0971.71.6918
headache2,5371.41.3253
death2,7381.11.013

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.